DNMT1 and peripheral arterial disease: Both DNMT1, which functions in DNA methylation maintenance, and DNMT3A, a de novo DNA methylation enzyme, are highly expressed in lower limb arteries of PAD patients and lowest expression is present in lower limb veins of PAD patients with critical ischemia.